Improved molecular detection of mosaicism in Beckwith-Wiedemann Syndrome
- 19 May 2020
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 58 (3), 178-184
- https://doi.org/10.1136/jmedgenet-2019-106498
Abstract
Background Beckwith-Wiedemann Syndrome (BWS) is characterised by overgrowth and tumour predisposition. While multiple epigenetic and genetic mechanisms cause BWS, the majority are caused by methylation defects in imprinting control regions on chromosome 11p15.5. Disease-causing methylation defects are often mosaic within affected individuals. Phenotypic variability among individuals with chromosome 11p15.5 defects and tissue mosaicism led to the definition of the Beckwith-Wiedemann Spectrum (BWSp). Molecular diagnosis of BWSp requires use of multiple sensitive diagnostic techniques to reliably detect low-level aberrations. Methods Multimodal BWS diagnostic testing was performed on samples from 1057 individuals. Testing included use of a sensitive qRT-PCR-based quantitation method enabling identification of low-level mosaic disease, identification of CNVs within 11p15.5 via array comparative genomic hybridisation or qRT-PCR, and Sanger sequencing of CDKN1C. Results A molecular diagnosis was confirmed for 27.4% of individuals tested, of whom 43.4% had mosaic disease. The presence of a single cardinal feature was associated with a molecular diagnosis of BWSp in 20% of cases. Additionally, significant differences in the prevalence of mosaic disease among BWS molecular subtypes were identified. Finally, the diagnostic yield obtained by testing solid tissue samples from individuals with negative blood testing results shows improved molecular diagnosis. Conclusion This study highlights the prevalence of mosaic disease among individuals with BWSp and the increases in diagnostic yield obtained via testing both blood and solid tissue samples from affected individuals. Additionally, the results establish the presence of a molecular diagnosis in individuals with very subtle features of BWSp.Keywords
Funding Information
- St Baldrick’s Foundation
- National Institutes of Health (K08 CA193915)
- Alex's Lemonade Stand Foundation for Childhood Cancer
This publication has 35 references indexed in Scilit:
- American College of Medical Genetics standards and guidelines for interpretation and reporting of postnatal constitutional copy number variantsGenetics in Medicine, 2011
- Multiplex ligation-depending probe amplification is not suitable for detection of low-grade mosaicismEuropean Journal of Human Genetics, 2011
- Allele-specific methylated multiplex real-time quantitative PCR (ASMM RTQ-PCR), a powerful method for diagnosing loss of imprinting of the 11p15 region in Russell Silver and Beckwith Wiedemann syndromesHuman Mutation, 2010
- Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridizationGenetics in Medicine, 2010
- Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysisHuman Molecular Genetics, 2010
- Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted lociHuman Molecular Genetics, 2009
- MS-MLPA is a specific and sensitive technique for detecting all chromosome 11p15.5 imprinting defects of BWS and SRS in a single-tube experimentEuropean Journal of Human Genetics, 2008
- Methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) robustly detects and distinguishes 11p15 abnormalities associated with overgrowth and growth retardationJournal of Medical Genetics, 2007
- Molecular subtypes and phenotypic expression of Beckwith–Wiedemann syndromeEuropean Journal of Human Genetics, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001